Indian vaccine innovation: the case of Shantha Biotechnics
<p>Abstract</p> <p>Background</p> <p>Although the World Health Organization had recommended that every child be vaccinated for Hepatitis B by the early 1980s, large multinational pharmaceutical companies held monopolies on the recombinant Hepatitis B vaccine. At a price...
Main Authors: | Heys Jennifer, Perampaladas Kumar, Masum Hassan, Chakma Justin, Singer Peter A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Globalization and Health |
Online Access: | http://www.globalizationandhealth.com/content/7/1/9 |
Similar Items
-
Franchising rabies vaccine delivery: the case of Indian immunologicals.
by: Hassan Masum, et al.
Published: (2011-01-01) -
Modeling Biotechnical Systems in Sports
by: А. О. Лопатьєв, et al.
Published: (2017-12-01) -
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model
by: Singer Peter A, et al.
Published: (2010-12-01) -
Economic Impacts of Biotechnical Innovations in the U.S. and Arizona Dairy and Cotton Industries
by: Gum, Russell L., et al.
Published: (1990) -
BIOTECHNICAL SYSTEM FOR INTEGRATED OLFACTOMETRY DIAGNOSTICS
by: Yana Nosova, et al.
Published: (2017-09-01)